“Alleanza Contro il Cancro” (ACC), an important Italian cancer research organization, has published an expression of interest that aims, through the harmonization and automation of processes, to reduce costs related to the CAR-T cell manufacturing and to implement production capabilities, building a national network open to the participation of other pharmaceutical and industrial companies.